Exact Sciences Corp.

Exact Sciences HQ

Exact Sciences Corp

Exact Sciences Corp is a biotechnology company headquartered in Madison, Wisconsin. The company focuses on the development and commercialization of non-invasive cancer screening tests.

History[edit | edit source]

Exact Sciences Corp was founded in 1995 by Kevin T. Conroy. The company initially focused on developing diagnostic tests for colorectal cancer. In 2009, Exact Sciences Corp launched its flagship product, Cologuard, a non-invasive screening test for colorectal cancer.

Products[edit | edit source]

Cologuard Cologuard is a non-invasive screening test for colorectal cancer that analyzes stool samples for the presence of DNA biomarkers and blood. The test is designed to detect early signs of colorectal cancer and precancerous lesions.

Research and Development[edit | edit source]

Exact Sciences Corp invests heavily in research and development to improve the accuracy and efficiency of its cancer screening tests. The company collaborates with leading research institutions and healthcare providers to advance the field of cancer diagnostics.

Partnerships[edit | edit source]

Exact Sciences Corp has established partnerships with various healthcare organizations and laboratories to expand the availability of its cancer screening tests. These partnerships help ensure that patients have access to innovative screening technologies.

Recognition[edit | edit source]

In 2014, Exact Sciences Corp received approval from the U.S. Food and Drug Administration for Cologuard, making it the first non-invasive screening test for colorectal cancer to receive FDA approval.